Focus on Transitional Disease: A Critical Interval to Delay Progression of Prostate Cancer
Oncology (Williston Park)
.
2021 Apr 19;35(4):166.
doi: 10.46883/ONC.2021.3504.0166.
Authors
E David Crawford
1
,
Christopher J Kane
1
,
Richard G Harris
2
,
Alan H Bryce
3
,
Daniel P Petrylak
4
Affiliations
1
UC San Diego School of Medicine, San Diego, CA.
2
UroPartners, Chicago, IL.
3
Mayo Clinic, Scottsdale, AZ.
4
Yale University School of Medicine, New Haven, CT.
PMID:
33872479
DOI:
10.46883/ONC.2021.3504.0166
No abstract available
MeSH terms
Antineoplastic Agents / therapeutic use
Disease Progression
Humans
Male
Prostatic Neoplasms / diagnosis*
Prostatic Neoplasms / diagnostic imaging
Prostatic Neoplasms / pathology*
Research Design
Substances
Antineoplastic Agents